#1 Clinical Trials Search in Europe

Proline

This article delves into the various clinical trials utilizing Proline, a compound that has shown promise in treating a range of conditions. From diabetes management to blood disorders like polycythemia vera, Proline-based medications are being studied for their potential to improve patient outcomes. We’ll explore the different applications, efficacy, and safety profiles of Proline-containing drugs across multiple clinical studies.

Table of Contents

What is PROLINE?

PROLINE is a medication that appears in various forms and is used to treat several different conditions. Based on the clinical trials data, we can see that PROLINE is often combined with other substances to create specialized medications. Some of the forms mentioned in the trials include:[1][2][4]

  • Henagliflozin Proline: A medication used for treating diabetes and chronic kidney disease.
  • Pegylated Proline Interferon Alpha-2b (also known as AOP2014): Used in the treatment of blood disorders like polycythemia vera and chronic myeloid leukemia.

Conditions Treated by PROLINE

PROLINE-based medications are used to treat a variety of conditions, including:[1][2][4][5]

  • Diabetes in Adults: Henagliflozin Proline is used to help control blood sugar levels in adults with type 2 diabetes.
  • Chronic Kidney Disease (CKD): Henagliflozin Proline is being studied for its potential benefits in patients with CKD.
  • Chronic Myeloid Leukemia (CML): Pegylated Proline Interferon Alpha-2b is used to maintain remission in patients with CML.
  • Polycythemia Vera (PV): This is a blood disorder where the body produces too many red blood cells. Pegylated Proline Interferon Alpha-2b is used to control the disease and its symptoms.

How PROLINE Works

The mechanism of action for PROLINE-based medications varies depending on the specific formulation and condition being treated:[1][4][5]

  • For diabetes and kidney disease: Henagliflozin Proline likely works by helping the kidneys remove excess sugar from the body through urine, which can help control blood sugar levels and potentially protect kidney function.
  • For blood disorders: Pegylated Proline Interferon Alpha-2b works by influencing the immune system and the blood-forming cells in the bone marrow. It can help suppress the abnormal cells causing the disease and promote the growth of healthy blood cells.

Administration of PROLINE

The way PROLINE is administered depends on the specific formulation:[1][4][6]

  • Henagliflozin Proline: This is typically taken orally as a tablet.
  • Pegylated Proline Interferon Alpha-2b (AOP2014): This medication is administered as a subcutaneous injection (an injection under the skin). It’s available in a pre-filled pen for self-administration, making it more convenient for patients to use at home.

PROLINE in Clinical Trials

Several clinical trials are being conducted to evaluate the efficacy and safety of PROLINE-based medications:[1][2][4][5]

  • Diabetes and Kidney Disease: Studies are looking at how Henagliflozin Proline interacts with other medications and its effects on kidney function and protein in the urine.
  • Chronic Myeloid Leukemia: Researchers are investigating whether Pegylated Proline Interferon Alpha-2b can help maintain remission in patients who have stopped their regular leukemia treatment.
  • Polycythemia Vera: Long-term studies are assessing the efficacy and safety of Pegylated Proline Interferon Alpha-2b in controlling the disease compared to other standard treatments.

Potential Side Effects

As with any medication, PROLINE-based drugs may cause side effects. The specific side effects can vary depending on the formulation and condition being treated. Some potential side effects being monitored in clinical trials include:[3][5]

  • Hypoglycemia (low blood sugar)
  • Dehydration or hypovolemia (decreased blood volume)
  • Urinary tract infections
  • Genital infections
  • Changes in blood pressure
  • Changes in body weight

It’s important to note that these are potential side effects being studied, and not all patients will experience them. Always consult with your healthcare provider about possible side effects and how to manage them.

Proline-based Drug Condition Studied Key Outcomes Measured Administration Method
Henagliflozin Proline Type 2 Diabetes Mellitus, Chronic Kidney Disease Changes in HbA1c, UACR, eGFR, blood pressure Oral
AOP2014 (Pegylated Proline Interferon Alpha-2b) Chronic Myeloid Leukemia, Polycythemia Vera Molecular relapse-free survival, hematocrit, white blood cell count, platelet count Subcutaneous injection
Ipragliflozin L-proline Type 2 Diabetes Mellitus Changes in HbA1c, fasting plasma glucose, body weight, blood pressure Oral

FAQ

  • What conditions are being studied using Proline-based medications? Clinical trials are exploring Proline-based medications for various conditions, including Type 2 Diabetes Mellitus, Chronic Kidney Disease, Polycythemia Vera, and Chronic Myeloid Leukemia in remission.
  • How is Henagliflozin Proline being studied for diabetes? Henagliflozin Proline is being studied in combination with other medications like Hydrochlorothiazide to assess drug-drug interactions and its efficacy in managing blood sugar levels in patients with Type 2 Diabetes Mellitus.
  • What is AOP2014, and how is it being used in clinical trials? AOP2014, also known as Pegylated Proline Interferon Alpha-2b, is being studied for its efficacy in maintaining remission in Chronic Myeloid Leukemia patients and for treating Polycythemia Vera. It's administered subcutaneously and is being evaluated for its long-term efficacy and safety.
  • Are there any self-administration studies for Proline-based medications? Yes, there is a study assessing the self-administration of AOP2014 using a pre-filled pen for patients with Polycythemia Vera. The study aims to evaluate the ease of self-administration and maintain blood efficacy parameters.
  • What are some common outcomes being measured in these Proline-related clinical trials? Common outcomes include changes in blood parameters (such as HbA1c, hematocrit, white blood cell count, and platelet count), disease response rates, quality of life measures, adverse events, and in some cases, the ease of medication administration.

Ongoing Clinical Trials on Proline

  • Study of Intradialytic Parenteral Nutrition for Muscle Protein Production in Patients on Long-term Hemodialysis Treatment

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Nutrition Methods and Muscle Loss After Esophagectomy Using SmofKabiven and Drug Combination for Patients Recovering from Esophageal Surgery

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Early vs. Delayed Supplementary Parenteral Nutrition with SmofKabiven for Patients After Major Emergency Abdominal Surgery

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Proline: An amino acid used in various medical compounds being studied for conditions like diabetes and blood disorders.
  • Henagliflozin Proline: A medication being studied for the treatment of Type 2 Diabetes Mellitus, often in combination with other drugs.
  • AOP2014: Also known as Pegylated Proline Interferon Alpha-2b, a medication being studied for blood disorders like Polycythemia Vera and Chronic Myeloid Leukemia.
  • Polycythemia Vera (PV): A blood disorder where the bone marrow produces too many red blood cells, often leading to thickened blood and increased risk of blood clots.
  • Chronic Myeloid Leukemia (CML): A type of cancer that starts in certain blood-forming cells of the bone marrow.
  • HbA1c: Glycated hemoglobin, a form of hemoglobin used to diagnose diabetes and assess long-term blood sugar control.
  • Hematocrit (Hct): The percentage of red blood cells in the blood, used to diagnose and monitor various blood conditions.
  • Platelets (PLTs): Small blood cells that help with blood clotting.
  • White Blood Cells (WBCs): Cells of the immune system that help fight infection and disease.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and excreted by the body.
  • UACR: Urine Albumin-to-Creatinine Ratio, a test used to detect kidney damage.
  • eGFR: Estimated Glomerular Filtration Rate, a test used to check how well the kidneys are working.
  • Molecular Remission: A state in cancer treatment where no detectable cancer cells are found using sensitive molecular techniques.
  • Best Available Therapy (BAT): The most effective known treatment option for a particular condition, as determined by a healthcare provider.

References

  1. https://clinicaltrials.gov/study/NCT06083116
  2. https://clinicaltrials.gov/study/NCT06221059
  3. https://clinicaltrials.gov/study/NCT02794792
  4. https://clinicaltrials.gov/study/NCT03117816
  5. https://clinicaltrials.gov/study/NCT02218047
  6. https://clinicaltrials.gov/study/NCT02523638